ArticlePloS one2018

FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.

Zhahirul Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.